- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02763670
Patient Care Management Strategies for Severe Heart Failure in Rhône-Alpes, France. (EFFICARD)
Comparison of Patient Care Management Strategies of Heart Failure in the Rhône-Alpes Region. A Clinical and Economic Study.
The heart failure is a chronic pathology with prevalence from 2 to 3% of general population, a death rate of 50% at 6 months for patients with stage IV, and a probability of death or hospitalization or emergency consultation of 40% at 3 years. The care of patients is heterogeneous, especially in light of the organization of therapeutic education offered to patients and patient monitoring modalities.
The aim of this study is to investigate the management strategies for patients with chronic heart failure stage III or IV NYHA, and heart failure patients with stage II NYHA with previous hospitalization for heart failure.
This is a longitudinal observational multicenter study comparing a management strategy including patient education and monitoring as part of a hospital dedicated organization and an organization of care as usually done in France.
The primary endpoint was a composite endpoint of morbidity and mortality involving deaths, unplanned readmissions and emergency visits for heart failure.
The expected number of patients is 720 patients (360 per strategy). The follow-up duration of 24 months.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bron, France
- Hospices Civils de Lyon
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Chronic heart failure patient with left ventricular ejection fraction (LVEF) defined by an impaired LVEF less than or equal to 40%.
- Heart failure stage III or IV NYHA, or heart failure patients with stage II NYHA with previous hospitalization for heart failure.
- Patient who has received a written or oral information of the study
- Patient affiliated with French health Insurance
Exclusion Criteria:
- Patient refusal to participate in the study
- Progressive neoplastic pathology.
- Patient with impaired cognitive functions known.
- Patient subject to a measure of socio-legal protection.
- Heart failure secondary to curable causes (an arrhythmia, valvular dysfunction, myocardial infarction, bypass surgery scheduled, aortic stenosis, breaking rope…)
- Dyspnea pulmonary origin: pulmonary arterial hypertension pre-capillary origin catheterization, defined by a Pcap ≤15 mmHg.
- Patient who underwent ventricular mechanical assistance.
- Patient with acute breathlessness is explained by: a severe lung infection (CPT <60% of predicted, ventricular ejection fraction <60% predicted) or pulmonary embolism or respiratory failure with ambient air PaO2 (arterial oxygen pressure) below 60 mmHg or oxygen therapy.
- Dialysis patient
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Interventional
PRETICARD patient care management
|
A standardized and specialized network to take care of the severe cardiac insufficiency:
|
|
Other: Control
Heterogenous "as usual" patient care management.
|
Conventional management of heart failure patients is defined in the guide HAS ("Haute Autorité de Santé") care course. Patient follow-up, however, is defined by the patient's physician and / or cardiologist at the waning of his hospitalization, according to the usual practice for patients with stage II, III or IV NYHA. According to these recommendations, the patient should see his cardiologist at least once a year. Usual practices are:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Composite endpoint combining the proportion of patients who died, the proportion of hospitalization for heart failure as well as the proportion of emergency visits for heart failure.
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Unplanned re hospitalization rate or emergency consultations for cardiac insufficiency.
Time Frame: At 6, 18 and 24 months
|
At 6, 18 and 24 months
|
|
|
Quality of life.
Time Frame: 12 months
|
MINNESOTA Questionnaire.
|
12 months
|
|
Satisfaction.
Time Frame: 3 months
|
Semi-structured interviews.
|
3 months
|
|
Cost of medical care
Time Frame: 24 months
|
Identification of expenditure:
|
24 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013.838
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe Heart Failure
-
LMU KlinikumRecruitingHeart Failure With Severe Tricuspid RegurgitationGermany
-
Centro Cardiologico MonzinoCompleted
-
Medical University of SilesiaMilitary Institute of Medicine, Poland; Clinical Hospital No. 2 Pomeranian... and other collaboratorsUnknownAtrial Fibrillation | Severe Heart FailurePoland
-
LMU KlinikumHeart Center Leipzig - University Hospital; Deutsches Zentrum für Herz-Kreislauf-Forschung... and other collaboratorsActive, not recruitingHeart Failure Attributable to Severe Tricuspid RegurgitationGermany
-
Ancora Heart, Inc.CompletedSevere Functional Mitral Regurgitation and Heart FailureAustralia
-
Kantonsspital OltenRecruitingCongestive Heart Failure | Activities of Daily Living | Exercise Capacity | Elderly Person | Electric Muscle Stimulation | Severe DeconditionSwitzerland
-
Peking Union Medical College HospitalBeijing Chest Hospital; Shanghai University of Traditional Chinese Medicine; Beijing... and other collaboratorsNot yet recruitingSevere Pneumonia With Respiratory Failure
-
Rennes University HospitalCompleted
-
Mespere Lifesciences Inc.Wayne State UniversityUnknownSevere Sepsis | Acute Heart FailureUnited States
-
University of VermontMedical University of South Carolina; University of Washington; University of...CompletedEnd Stage Renal Disease | Severe Life-limiting COPD | Severe Life-limiting Heart Failure | Severe Life-limiting Cirrhosis | Severe Life-limiting Malignancy | Severe Functional ImpairmentUnited States
Clinical Trials on PRETICARD patient care management
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Johns Hopkins Bloomberg School of Public HealthWhite Mountain Apache Tribe; Native American Research Center for HealthRecruiting
-
Denver Health and Hospital AuthorityUniversity of Colorado, DenverCompletedObesity | Overweight | ChildrenUnited States
-
University of ChicagoActive, not recruitingDiabetes Mellitus, Type 1United States
-
Renato Cagnacci NetoM.D. Anderson Cancer Center; Eduardo Mondlane University; Hospital Central de... and other collaboratorsCompletedA Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients (NAVIMOZ)Breast Neoplasm Malignant PrimaryMozambique
-
Virginia Commonwealth UniversityStand Up To CancerRecruiting
-
Yale UniversityNational Eye Institute (NEI)CompletedDiabetic Retinopathy | Diabetic BlindnessUnited States
-
Institut National de la Santé Et de la Recherche...National Cancer Institute, FranceCompletedColorectal Cancer ScreeningFrance
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingKidney StonesUnited States
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of Mental Health (NIMH)CompletedSuicide | Depressive Symptoms | Substance Use | Mental Health | SurveillanceUnited States